Repair Biotechnologies

Syracuse, NY · Founded 2018 · Privately Held (backing)

Operator of a preclinical biotechnology company intended to develop drugs for cholesterol and aging-related diseases. Repair Biotechnologies is based in Syracuse, NY and was founded in 2018. It was valued at $74.4 million at its seed round in Nov 2025, the last priced event on record. It has raised $22.9 million across 6 recorded rounds; the latest was a $5.3 million early-stage round in Nov 2025.

PMV mark · valuation
$74.4M
Oct 2026
Priced at
its seed round
Nov 2025
Total raised
$22.9M
Last round
Early Stage VC
Nov 2025

Who backs Repair Biotechnologies?

14 investors
InvestorType
100 Plus Capital—
Bioverge Ventures—
Emerging Longevity Ventures—
Healthspan Capital—
James Mellon—
Karl Pfleger—
Kenneth Scott—
Lifespan Extension Advocacy Foundation—
LongGame—
Longevitytech.fund—
+ 4 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Repair Biotechnologies investors

14 investors are on record for Repair Biotechnologies, including 100 Plus Capital, Bioverge Ventures, Emerging Longevity Ventures and Healthspan Capital. The early-stage round in Nov 2025 drew 16 investors.

Free account
More of Repair Biotechnologies with a free account
  • ·The complete investor list: 14 names
  • ·Watch Repair Biotechnologies: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 14 firms already write checks for companies like Repair Biotechnologies. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View